3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Expanded_access
1
Sponsor
Cancer Type
Dermatologic
1
CNS
1
Conditions
Melanoma
1
Glioma
1
Glioblastoma
1
Interventions
ulixertinib
1
rindopepimut
1
pembrolizumab
1
mogamulizumab
1
gallium maltolate
1
efineptakin alfa
1
Proton Pump Inhibitors
1
Ipilimumab
1
Hydrocortisone
1
Cancer Vaccines
1
Adjuvants, Immunologic
1
ABT-414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Glioblastoma
×
efineptakin alfa
×
Clear all
NCT04289155
2022-03-17
Individual Patient Compassionate Use of GX-I7
Genexine, Inc.
No longer available